Agilent Technologies, Inc. with ticker code (A) have now 15 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The target price High/Low ranges between 163 and 110 suggesting an average Analsyt target price of $139.13. Now with the previous closing price of $112.69 this would imply there is now a potential upside of 23.5%. It’s also worth noting that there is a 50 day moving average of $121.31 and the 200 day MA is $134.05. The market capitalization for the company is 32.86B. The stock price for the company is currently is currently 112.31 USD
The potential market cap would be $40,570,360,743 based on the market consensus.
The company has a dividend yield of 2.35%. Other points of data to note are a P/E ratio of 29.4, revenue per share of 23.69 and a 8.79% return on assets.
Agilent Technologies, Inc. is engaged in providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. It operates in the life sciences, diagnostics and applied chemical markets. Its life sciences and applied markets business offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics businesses are comprised of six areas of activity, providing active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software, and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. Its product categories include liquid chromatography systems and components and liquid chromatography mass spectrometry systems.
